of the year 2019. The revenues is from the remaining project which is almost complete, and which is in the process of testing the system and handing over to the owner. The Company will start

the 2019, HM has more free production capacity to support external customers. In second half of 2019, HM received more orders from the products that passed main overseas customer’ testing and was able

revenue has continuously grown mainly due to its greater expansion of laboratory scopes of testing and analyzing for agricultural, food, and pharmaceutical associated with continual growing number of

metal packaging industry. After some of new products sample had been introduced to customers for testing, we start to receive orders from Thailand customers in the end of 3rd quarter. Our plan is to

activities of corporate bonds and being ready to open opportunities for additional securities issuers and market participants to take part in the system testing and create investment innovations for

statements of STARK, for the years 2019-2021, constituted a serious failure to comply with auditing standards regarding risk assessment and audit planning, journal entry testing, analytical procedures

loophole of program of system software such as DBMS operational system and web server etc.. [M] · Testing the system software related to the security and operation effectiveness prior to installment and

operational system in order to fill consistently a loophole of program of system software such as DBMS operational system and web server etc..[M] o Testing the system software related to the security and

products that has not yet the competitor. And has been researching and good testing. 4. Details of acquired assets Details of the BS Myco Biotech Company Limited as follows: 4.1 General information

more orders from the products that passed main overseas customer’ testing from Q1-2 and also delivered a big lot of items, resulting in the increased revenue in second half of 2019. Overall, the Company